U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07079540) titled 'The Phase III Clinical Trial of X842 Capsules for Reflux Esophagitis' on July 14.
Brief Summary: To evaluate the efficacy and safety of X842 Capsules 50 mg compared to Lansoprazole Enteric Capsules for the treatment of reflux esophagitis, and to characterize the population pharmacokinetics of X842 capsules in this patient population.
Study Start Date: June 24, 2021
Study Type: INTERVENTIONAL
Condition:
Reflux Esophagitis
Intervention:
DRUG: X842
X842 capsules
DRUG: X842 Placebo
X842 placebo-matching capsules
DRUG: Lansoprazole
Lansoprazole capsules
DRUG: Lansoprazole Placebo
Lansoprazole placebo-matching capsules
Recru...